• Forendo Pharma Initiates Endometriosis Study americanpharmaceuticalreview
    July 11, 2018
    Forendo Pharma has received clinical trial authorization (CTA) from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) to commence a study for its lead program FOR-6219.
PharmaSources Customer Service